Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYOBLOC in Troublesome Sialorrhea
NCT02610868Phase 3Completed
- Sponsor
- US WorldMeds
- Start
- Oct 2015
- Primary completion
- Jun 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of botulinum toxin type b in sialorrhea, sponsored by US WorldMeds. Started Oct 2015; status: completed.
02
Drugs
botulinum toxin type b
03
Conditions
sialorrhea
Beyond the preview
Go deeper on NCT02610868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02610868.